Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

Expanded Recommendations for OBRONA

24 Jul 2024 07:00

RNS Number : 5304X
Plant Health Care PLC
24 July 2024
 

24 July 2024

 

Plant Health Care plc

 ("Plant Health Care" or the "Company")

 

Expanded Recommendations to Support Commercial Sales of OBRONA® Biochemical Fungicide for Use on Corn, Soybean, and Wheat

  

Plant Health Care® (AIM.PHC.L), a leading provider of peptides used by growers to improve crop production and quality within global agriculture markets, is pleased to announce the issuance of new recommendations for use of OBRONA® biochemical fungicide to provide farmers with another tool to control a wide range of diseases and improve crop yield and harvest quality in corn, soybean and wheat in key US states.

 

Highlights:

- The new Section 2(ee) recommendations cover the use of OBRONA to control diseases in the following crops:

· Control in corn of common rust, gray leaf spot, northern and southern corn leaf blight and tar spot,

· Control in soybean of downy mildew, frogeye leaf spot, sclerotinia stem rot, and white mold,

· Control in wheat of multiple rust species: black, leaf, stem, stripe, and yellow rust. 

- These diseases represent serious threats to agricultural production and can significantly reduce crop yields, harvest quality, and grower profitability if not properly managed. OBRONA provides growers with a novel mode of action and an environmentally friendly tool to control these diseases and support sustainable agriculture based on reduced reliance on established synthetic pesticides. 

 

Section 2(ee) of the Federal Insecticide, Fungicide and Rodenticide Act (FIFRA) allows users to apply pesticides under certain limited conditions that are not specified on the commercial label. The recommendations shown above have been written to address control of target pests not listed on the OBRONA label.

 

Compared to current biocontrol products, OBRONA provides highly consistent and convenient product performance to control a broad spectrum of fungal and bacterial plant diseases. In addition to providing growers with a favorable return on investment, OBRONA brings growers convenience as it is compatible with many commonly used fungicides, herbicides, and insecticides in tank-mix and sequential application programs. OBRONA has no special requirements for storing or handling, which allows greater flexibility within the distribution channel and ease of on-farm application.

  

Jeff Tweedy, CEO of Plant Health Care, said: ‟Wilbur-Ellis is aggressively launching OBRONA this summer across the mid-west for disease control in corn, soybean and wheat. Results from field testing of OBRONA are very promising and we are excited to continue working with Wilbur-Ellis to bring the benefits of OBRONA to a wide range of growers across the country for the 2024 season."

 

  

# # #

 

For further information, please contact: 

Plant Health Care plc Jeff Tweedy, CEO

 

Tel: +1 919 926 1600

 

 

Cavendish Capital Markets Limited - Nomad & Broker Neil McDonald / Pete Lynch

 

Tel: +44 (0) 131 220 9771

 

 

For further information about Wilbur-Ellis, please contact: Jeanne Forbis, jforbis@wilburellis.com

 

 

About Plant Health Care

Plant Health Care offers products to improve the health, vigour and yield of major field crops such as corn, soybeans, sugarcane, potatoes, rice, and wheat, as well as specialty crops such as fruits and vegetables. We operate globally through subsidiaries, distributors, and supply agreements with major industry partners. Our innovative, patent-protected biological products help growers to protect their crops from stress and diseases, and to produce higher quality fruit and vegetables, with a favourable environmental profile.

 

Find out more at www.planthealthcare.com

 

About the Wilbur-Ellis Companies 

Founded in 1921, the Wilbur-Ellis companies are leading marketers, distributors and manufacturers of agricultural products and animal nutrients. By developing strong relationships, making strategic market investments, and capitalizing on new opportunities, the Wilbur-Ellis companies have continued to grow the business with sales of over $3.5 billion. For more information, please visit www.wilburellis.com

Wilbur-Ellis Agriculture, with annual sales revenue of $2.5 billion, has over 150 retail locations throughout the U.S.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
REAQKNBKABKDQOB
Date   Source Headline
28th Jun 202312:29 pmRNSHolding(s) in Company
27th Jun 20234:08 pmRNSHolding(s) in Company
27th Jun 20231:08 pmRNSDirector Shareholding
23rd Jun 20237:00 amRNSResult of Fundraising
22nd Jun 20234:35 pmRNSFundraising to raise up to US$3.6 million
14th Jun 20237:00 amRNSWilbur Ellis Agreement
13th Jun 20231:43 pmRNSResult of AGM
30th May 20237:00 amRNSHolding(s) in Company
24th May 20231:12 pmRNSHolding(s) in Company
19th May 20235:55 pmRNSPublication of Annual Report and Notice of AGM
18th May 20237:00 amRNSResult of Consultation
9th May 20237:00 amRNSPHC68949 granted first stage of approval in Brazil
2nd May 20237:10 amRNSResults for the year ended 31 December 2022
12th Apr 20232:33 pmRNSNotice of Results
5th Apr 20235:29 pmRNSHolding(s) in Company
8th Mar 20232:45 pmRNSExercise of Options
2nd Mar 20237:00 amRNSBiofungicide PHC279 Approved by US EPA
1st Mar 20237:00 amRNSDirector/PDMR Shareholding
6th Feb 20237:00 amRNSTrading Statement
30th Jan 202312:08 pmRNSSignificant Shareholder
18th Jan 20237:00 amRNSBoard Appointments
12th Jan 20237:00 amRNSNovozymes Distribution Agreement
9th Jan 20237:00 amRNSInvestor Presentation
22nd Dec 20227:00 amRNSNew Products Submitted for Regulatory Approval
28th Oct 20227:00 amRNSRegistration of Harpin in France
28th Oct 20227:00 amRNSNew distribution agreement with EDAF
27th Oct 20227:00 amRNSTrading Update
14th Oct 20225:11 pmRNSDirector/PDMR Shareholding
14th Oct 202210:39 amRNSDirector / PDMR Shareholding
26th Sep 20227:00 amRNSInterim Results
22nd Aug 20227:00 amRNSTrials agreement signed with Agrii UK
12th Aug 20227:00 amRNSGrant of Options
10th Aug 20225:04 pmRNSDirector/PDMR Shareholding
21st Jul 20222:41 pmRNSHolding(s) in Company
18th Jul 20227:02 amRNSInvestor Presentation
18th Jul 20227:00 amRNSPost-Close Trading Update
22nd Jun 202212:37 pmRNSResult of AGM
21st Jun 20227:00 amRNSCompletion of Nominated Adviser due diligence
20th Jun 20227:00 amRNSLong-term Harpin Production and Supply Agreement
6th Jun 20228:00 amRNSHolding(s) in Company
6th Jun 20228:00 amRNSHolding(s) in Company
1st Jun 20222:31 pmRNSDirector/PDMR Shareholding
25th May 20225:23 pmRNSHolding(s) in Company
23rd May 20227:30 amRNSAnnual Report & Accounts and Notice of AGM
23rd May 20227:00 amRNSNew distribution agreement with Nutrien
16th May 20227:00 amRNSHolding(s) in Company
12th May 20227:15 amRNSCEO appointment and Board changes
12th May 20227:00 amRNSResults for the year ended 31 December 2021
28th Apr 20227:00 amRNSChange of Adviser
21st Apr 20222:27 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.